Bharali Dhruba J, Armstrong Donald, Mousa Shaker A
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA.
Methods Mol Biol. 2013;1028:279-86. doi: 10.1007/978-1-62703-475-3_18.
Nanotechnology that deals with submicron particles has the potential to deeply impact ophthalmic delivery owing to its ability to transport incorporated active ingredient/drugs to the different compartments of the eye while protecting them from any external assault. Polymeric nanoparticles, in particular hybrid nanoparticles made up of different biodegradable and biocompatible polymers, has the potential to revolutionize ocular delivery carrier systems by taking advantage of their highly tunable physicochemical properties. Here we report a synthesis method of hybrid nanoparticles made up of chitosan-poly(lactide-co-glycolide) (PLGA, as a building block of the nanocarrier) as a carrier for ophthalmic delivery. The synthesis method, characterization, and uptake study in retinal epithelial cells by confocal imaging is described herein.
处理亚微米颗粒的纳米技术因其能够将所含活性成分/药物输送到眼睛的不同部位,同时保护它们免受任何外部侵害,而具有深刻影响眼科给药的潜力。聚合物纳米颗粒,特别是由不同可生物降解和生物相容性聚合物组成的混合纳米颗粒,有可能通过利用其高度可调的物理化学性质,彻底改变眼部给药载体系统。在此,我们报告一种由壳聚糖-聚(丙交酯-共-乙交酯)(PLGA,作为纳米载体的构建块)组成的混合纳米颗粒的合成方法,作为眼科给药的载体。本文描述了该合成方法、表征以及通过共聚焦成像在视网膜上皮细胞中的摄取研究。